John Stewart Sharman - 25 Mar 2024 Form 4 Insider Report for UNIVERSAL BIOSENSORS INC

Role
Chief Executive Officer
Signature
/s/ John Sharman
Issuer symbol
N/A
Transactions as of
25 Mar 2024
Net transactions value
+$272,933
Form type
4
Filing time
25 Mar 2024, 18:45:51 UTC
Previous filing
03 Jan 2023
Next filing
03 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction UBI Common Stock Options Exercise $272,933 +1,364,666 +1706% $0.2000* 1,444,666 25 Mar 2024 Direct
holding UBI Common Stock 276,217 25 Mar 2024 By Wife F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UBI Stock Option (Right to Buy) Options Exercise $0 -1,364,666 -100% $0.000000* 0 25 Mar 2024 Common Stock 1,364,666 $0.2000 Direct F2, F3
holding UBI Performance Rights 2,500,000 25 Mar 2024 Common Stock 2,500,000 Direct F4
holding UBI Perforamnce Rights 1,250,000 25 Mar 2024 Common Stock 1,250,000 Direct F5
holding UBI Stock Option (Right to Buy) 2,364,667 25 Mar 2024 Common Stock 2,364,667 $0.2500 Direct F2, F3
holding UBI Stock Option (Right to Buy) 1,364,667 25 Mar 2024 Common Stock 1,364,667 $0.3000 Direct F2, F3
holding UBI Stock Option (Right to Buy) 1,000,000 25 Mar 2024 Common Stock 1,000,000 $0.3000 By superannuation fund F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of the shares held by his wife, and this report should not be deemed an admission that the reporting person is the beneficial owner of his wife's shares for purposes of Section 16 or for any other purpose.
F2 The price reported is stated in Australian dollars.
F3 The options are fully vested and became exercisable after September 24, 2020. The options expiring in March 2024 were exercised on March 25, 2024.
F4 Each performance right represents a contingent right to receive one share of common stock of Universal Biosensors, Inc. ("UBI"). The performance rights vest upon, among other triggers, UBI's market capitalization having achieved a specified threshold.
F5 Each performance right represents a contingent right to receive one share of common stock of UBI. The performance rights vest upon a change of control transaction with a value greater a specified threshold.